Bayer AG (id:2556 BAYN)
18.89 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/25/2024 4:11:01 PM)
Exchange open, closes in 1 hour 18 minutes
About Bayer AG
Market Capitalization 18.61B
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Headquarters (address) |
Kaiser-Wilhelm-Allee 1 Leverkusen 51368 Germany |
Phone | 49 214 30 1 |
Website | https://www.bayer.com |
Employees | 97K |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Ticker | BAYN |
Exchange | Xetra Frankfurt Stock Exchange |
Currency | EUR |
52 week range | 18.41 - 36.09 |
Market Capitalization | 18.61B |
Dividend yield forward | 2.33 % |
Dividend yield forward Germany (ID:66, base:265) | 13.16 % |
P/E trailing | 28.38 |
P/E forward | 3.56 |
Price/Sale | 3.00 |
Price/Book | 3.00 |
Beta | 1.00 |
EPS | 3.00 |
EPS Germany (ID:66, base:318) | 2.39 |
Dividend growth streak
Bayer AG has raised their dividend 1.00 years in a row. This is below the 4.499729 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Bayer AG has raised their dividend 2.33 years in a row. This is below the 42132.505900 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Bayer AG has raised their dividend 2.53 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Bayer AG has raised their dividend 163.27 years in a row. This is above the 148.467900 year average in the 'Drug Manufacturers General' industry
Dividend growth streak
Bayer AG has raised their dividend 1.00 years in a row. This is below the 4.499729 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Bayer AG has raised their dividend 2.33 years in a row. This is below the 42132.505900 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Bayer AG has raised their dividend 2.53 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Bayer AG has raised their dividend 163.27 years in a row. This is above the 148.467900 year average in the 'Drug Manufacturers General' industry